DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Tawbi H, Forsyth P, Algazi A. et al.
Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.
J Clin Oncol 2017;
35: 9507-9507
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.